Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Releases FY 2022 Earnings Guidance

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $7.86-$7.86 for the period. The company issued revenue guidance of $51.64 billion-$51.64 billion, compared to the consensus revenue estimate of $51.59 billion.

Several brokerages have commented on BAYRY. Barclays raised Bayer Aktiengesellschaft from an equal weight rating to an overweight rating in a research report on Tuesday, April 5th. Jefferies Financial Group assumed coverage on shares of Bayer Aktiengesellschaft in a research note on Monday, March 14th. They set a buy rating for the company. Citigroup upgraded shares of Bayer Aktiengesellschaft from a neutral rating to a buy rating in a research report on Monday, January 31st. UBS Group upped their price objective on shares of Bayer Aktiengesellschaft from €85.00 ($89.47) to €90.00 ($94.74) in a research report on Friday, March 11th. Finally, Morgan Stanley lifted their target price on Bayer Aktiengesellschaft from €77.00 ($81.05) to €83.00 ($87.37) and gave the stock an overweight rating in a research report on Monday, April 25th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of Buy and an average target price of $61.20.

Shares of Bayer Aktiengesellschaft stock traded down $0.34 during midday trading on Tuesday, reaching $15.56. The company had a trading volume of 645,085 shares, compared to its average volume of 583,362. The stock has a fifty day simple moving average of $16.58 and a 200 day simple moving average of $14.99. Bayer Aktiengesellschaft has a 1-year low of $12.45 and a 1-year high of $18.45. The company has a current ratio of 1.11, a quick ratio of 0.72 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $61.15 billion, a price-to-earnings ratio of 53.66, a price-to-earnings-growth ratio of 2.04 and a beta of 1.11.

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Rating) last released its earnings results on Tuesday, March 1st. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.10. The company had revenue of $12.72 billion during the quarter, compared to the consensus estimate of $11.68 billion. Bayer Aktiengesellschaft had a return on equity of 19.63% and a net margin of 2.17%. Sell-side analysts expect that Bayer Aktiengesellschaft will post 1.96 earnings per share for the current year.

The firm also recently announced a dividend, which will be paid on Monday, May 16th. Shareholders of record on Tuesday, May 3rd will be given a dividend of $0.3693 per share. The ex-dividend date is Monday, May 2nd. This represents a yield of 2.26%. Bayer Aktiengesellschaft’s payout ratio is presently 127.59%.

Bayer Aktiengesellschaft Company Profile (Get Rating)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

Further Reading

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with's FREE daily email newsletter.